Search

Your search keyword '"Allott, Emma"' showing total 351 results
Start Over Author "Allott, Emma"
351 results on '"Allott, Emma"'

1. ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancer

Author

Sheill, Gráinne, Brady, Lauren, Hayes, Brian, Baird, Anne-Marie, Guinan, Emer, Vishwakarma, Rishabh, Brophy, Caroline, Vlajnic, Tatjana, Casey, Orla, Murphy, Verena, Greene, John, Allott, Emma, Hussey, Juliette, Cahill, Fidelma, Van Hemelrijck, Mieke, Peat, Nicola, Mucci, Lorelei, Cunningham, Moya, Grogan, Liam, Lynch, Thomas, Manecksha, Rustom P., McCaffrey, John, O’Donnell, Dearbhaile, Sheils, Orla, O’Leary, John, Rudman, Sarah, McDermott, Ray, and Finn, Stephen

Published
2023
Full Text
View/download PDF

4. Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database.

Author

Allott, Emma H, Howard, Lauren E, Aronson, William J, Terris, Martha K, Kane, Christopher J, Amling, Christopher L, Cooperberg, Matthew R, and Freedland, Stephen J

Subjects
Humans, Prostatic Neoplasms, Neoplasm Recurrence, Local, Cholesterol, Retrospective Studies, Cohort Studies, Middle Aged, Male, Dyslipidemias, Black People, Cardiovascular, Cancer, Prostate Cancer, Urologic Diseases, Heart Disease, Atherosclerosis, Aging, Prevention, Blacks, Medical and Health Sciences, Epidemiology
Abstract

BackgroundBlack men are disproportionately affected by both cardiovascular disease and prostate cancer. Epidemiologic evidence linking dyslipidemia, an established cardiovascular risk factor, and prostate cancer progression is mixed. As existing studies were conducted in predominantly non-black populations, research on black men is lacking.MethodsWe identified 628 black and 1,020 non-black men who underwent radical prostatectomy and never used statins before surgery in the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Median follow-up was 2.9 years. The impact of preoperative hypercholesterolemia on risk of biochemical recurrence was examined using multivariable, race-stratified proportional hazards. In secondary analysis, we examined associations with low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides, overall and among men with dyslipidemia.ResultsHigh cholesterol was associated with increased risk of recurrence in black [HR(per10 mg/dL) 1.06; 95% confidence interval (CI), 1.02-1.11] but not non-black men (HR(per10 mg/dL) 0.99; 95% CI, 0.95-1.03; P(interaction) = 0.011). Elevated triglycerides were associated with increased risk in both black and non-black men (HR(per10 mg/dL) 1.02; 95% CI, 1.00-1.03 and 1.02; 95% CI, 1.00-1.02, respectively; P(interaction) = 0.458). There were no significant associations between LDL or HDL and recurrence risk in either race. Associations with cholesterol, LDL, and triglycerides were similar among men with dyslipidemia, but low HDL was associated with increased risk of recurrence in black, but not non-black men with dyslipidemia (P(interaction) = 0.047).ConclusionElevated cholesterol was a risk factor for recurrence in black but not non-black men, whereas high triglycerides were associated with increased risk regardless of race.ImpactSignificantly contrasting associations by race may provide insight into prostate cancer racial disparities.

Published
2016

6. Statin use and prostate cancer recurrence

Author

Allott, Emma H, Howard, Lauren E, Cooperberg, Matthew R, Kane, Christopher J, Aronson, William J, Terris, Martha K, Amling, Christopher L, and Freedland, Stephen J

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Research, Aging, Urologic Diseases, Cancer, Prostate Cancer, Aged, Databases, Factual, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Male, Middle Aged, Neoplasm Recurrence, Local, Postoperative Period, Proportional Hazards Models, Prostatectomy, Prostatic Neoplasms, Retrospective Studies, Risk, United States, biochemical recurrence, cholesterol, postoperative statin use, prostate cancer, Urology & Nephrology, Clinical sciences, Oncology and carcinogenesis
Abstract

ObjectiveTo investigate the effect of statin use after radical prostatectomy (RP) on biochemical recurrence (BCR) in patients with prostate cancer who never received statins before RP.Patients and methodsWe conducted a retrospective analysis of 1146 RP patients within the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Multivariable Cox proportional hazards analyses were used to examine differences in risk of BCR between post-RP statin users vs nonusers. To account for varying start dates and duration of statin use during follow-up, post-RP statin use was treated as a time-dependent variable. In a secondary analysis, models were stratified by race to examine the association of post-RP statin use with BCR among black and non-black men.ResultsAfter adjusting for clinical and pathological characteristics, post-RP statin use was significantly associated with 36% reduced risk of BCR (hazard ratio [HR] 0.64, 95% confidence interval [CI] 0.47-0.87; P = 0.004). Post-RP statin use remained associated with reduced risk of BCR after adjusting for preoperative serum cholesterol levels. In secondary analysis, after stratification by race, this protective association was significant in non-black (HR 0.49, 95% CI 0.32-0.75; P = 0.001) but not black men (HR 0.82, 95% CI 0.53-1.28; P = 0.384).ConclusionIn this retrospective cohort of men undergoing RP, post-RP statin use was significantly associated with reduced risk of BCR. Whether the association between post-RP statin use and BCR differs by race requires further study. Given these findings, coupled with other studies suggesting that statins may reduce risk of advanced prostate cancer, randomised controlled trials are warranted to formally test the hypothesis that statins slow prostate cancer progression.

Published
2014

7. Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database

Author

Allott, Emma H, Howard, Lauren E, Cooperberg, Matthew R, Kane, Christopher J, Aronson, William J, Terris, Martha K, Amling, Christopher L, and Freedland, Stephen J

Subjects
Urologic Diseases, Cancer, Prevention, Atherosclerosis, Aging, Prostate Cancer, Patient Safety, Cardiovascular, 2.1 Biological and endogenous factors, Aetiology, Aged, Cholesterol, Databases, Factual, Dyslipidemias, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipids, Lipoproteins, HDL, Lipoproteins, LDL, Male, Middle Aged, Neoplasm Recurrence, Local, Prostate-Specific Antigen, Prostatectomy, Prostatic Neoplasms, Retrospective Studies, Risk Assessment, Triglycerides, Medical and Health Sciences, Epidemiology
Abstract

BackgroundEvidence for an association between total cholesterol, low- and high-density lipoproteins (LDL and HDL, respectively), triglycerides, and prostate cancer is conflicting. Given that prostate cancer and dyslipidemia affect large proportions of Western society, understanding these associations has public health importance.MethodsWe conducted a retrospective cohort analysis of 843 radical prostatectomy (RP) patients who never used statins before surgery within the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Multivariable Cox proportional hazards analysis was used to investigate the association between cholesterol, LDL, HDL, and triglycerides and biochemical recurrence risk. In secondary analysis, we explored these associations in patients with dyslipidemia, defined using National Cholesterol Education Program guidelines.ResultsElevated serum triglycerides were associated with increased risk of prostate cancer recurrence [HRper 10 mg/dl, 1.03; 95% confidence interval (CI), 1.01-1.05] but associations between total cholesterol, LDL and HDL, and recurrence risk were null. However, among men with dyslipidemia, each 10 mg/dl increase in cholesterol and HDL was associated with 9% increased recurrence risk (HR, 1.09; 95% CI, 1.01-1.17) and 39% reduced recurrence risk (HR, 0.61; 95% CI, 0.41-0.91), respectively.ConclusionsElevated serum triglycerides were associated with increased risk of prostate cancer recurrence. Cholesterol, LDL, or HDL were not associated with recurrence risk among all men. However, among men with dyslipidemia, elevated cholesterol and HDL levels were associated with increased and decreased risk of recurrence, respectively.ImpactThese findings, coupled with evidence that statin use is associated with reduced recurrence risk, suggest that lipid levels should be explored as a modifiable risk factor for prostate cancer recurrence.

Published
2014

8. Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

Author

Allott, Emma H, Howard, Lauren E, Cooperberg, Matthew R, Kane, Christopher J, Aronson, William J, Terris, Martha K, Amling, Christopher L, and Freedland, Stephen J

Subjects
Humans, Prostatic Neoplasms, Neoplasm Recurrence, Local, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Postoperative Period, Prostatectomy, Proportional Hazards Models, Risk, Retrospective Studies, Databases, Factual, Aged, Middle Aged, United States, Male, biochemical recurrence, cholesterol, postoperative statin use, prostate cancer, Neoplasm Recurrence, Local, Databases, Factual, Urology & Nephrology, Clinical Sciences
Abstract

ObjectiveTo investigate the effect of statin use after radical prostatectomy (RP) on biochemical recurrence (BCR) in patients with prostate cancer who never received statins before RP.Patients and methodsWe conducted a retrospective analysis of 1146 RP patients within the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Multivariable Cox proportional hazards analyses were used to examine differences in risk of BCR between post-RP statin users vs nonusers. To account for varying start dates and duration of statin use during follow-up, post-RP statin use was treated as a time-dependent variable. In a secondary analysis, models were stratified by race to examine the association of post-RP statin use with BCR among black and non-black men.ResultsAfter adjusting for clinical and pathological characteristics, post-RP statin use was significantly associated with 36% reduced risk of BCR (hazard ratio [HR] 0.64, 95% confidence interval [CI] 0.47-0.87; P = 0.004). Post-RP statin use remained associated with reduced risk of BCR after adjusting for preoperative serum cholesterol levels. In secondary analysis, after stratification by race, this protective association was significant in non-black (HR 0.49, 95% CI 0.32-0.75; P = 0.001) but not black men (HR 0.82, 95% CI 0.53-1.28; P = 0.384).ConclusionIn this retrospective cohort of men undergoing RP, post-RP statin use was significantly associated with reduced risk of BCR. Whether the association between post-RP statin use and BCR differs by race requires further study. Given these findings, coupled with other studies suggesting that statins may reduce risk of advanced prostate cancer, randomised controlled trials are warranted to formally test the hypothesis that statins slow prostate cancer progression.

Published
2014

14. Data from PAM50 and Risk of Recurrence Scores for Interval Breast Cancers

Author

Puvanesarajah, Samantha, primary, Nyante, Sarah J., primary, Kuzmiak, Cherie M., primary, Chen, Mengjie, primary, Tse, Chiu-Kit, primary, Sun, Xuezheng, primary, Allott, Emma H., primary, Kirk, Erin L., primary, Carey, Lisa A., primary, Perou, Charles M., primary, Olshan, Andrew F., primary, Henderson, Louise M., primary, and Troester, Melissa A., primary

Published
2023
Full Text
View/download PDF

15. Supplemental Tables 1-3 from PAM50 and Risk of Recurrence Scores for Interval Breast Cancers

Author

Puvanesarajah, Samantha, primary, Nyante, Sarah J., primary, Kuzmiak, Cherie M., primary, Chen, Mengjie, primary, Tse, Chiu-Kit, primary, Sun, Xuezheng, primary, Allott, Emma H., primary, Kirk, Erin L., primary, Carey, Lisa A., primary, Perou, Charles M., primary, Olshan, Andrew F., primary, Henderson, Louise M., primary, and Troester, Melissa A., primary

Published
2023
Full Text
View/download PDF

17. Supplemental Figure 1 from PAM50 and Risk of Recurrence Scores for Interval Breast Cancers

Author

Puvanesarajah, Samantha, primary, Nyante, Sarah J., primary, Kuzmiak, Cherie M., primary, Chen, Mengjie, primary, Tse, Chiu-Kit, primary, Sun, Xuezheng, primary, Allott, Emma H., primary, Kirk, Erin L., primary, Carey, Lisa A., primary, Perou, Charles M., primary, Olshan, Andrew F., primary, Henderson, Louise M., primary, and Troester, Melissa A., primary

Published
2023
Full Text
View/download PDF

19. Associations between statin use and prostate cancer aggressiveness, overall and stratified by race and additionally adjusted for education, income and family history of prostate cancer. from Statin Use and Prostate Cancer Aggressiveness: Results from the Population-Based North Carolina–Louisiana Prostate Cancer Project

Author

Allott, Emma H., primary, Farnan, Laura, primary, Steck, Susan E., primary, Arab, Lenore, primary, Su, L. Joseph, primary, Mishel, Merle, primary, Fontham, Elizabeth T.H., primary, Mohler, James L., primary, and Bensen, Jeannette T., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Materials and Methods. Immunohistochemical staining and automated analysis methods from Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

Author

Allott, Emma H., primary, Cohen, Stephanie M., primary, Geradts, Joseph, primary, Sun, Xuezheng, primary, Khoury, Thaer, primary, Bshara, Wiam, primary, Zirpoli, Gary R., primary, Miller, C. Ryan, primary, Hwang, Helena, primary, Thorne, Leigh B., primary, O'Connor, Siobhan, primary, Tse, Chiu-Kit, primary, Bell, Mary B., primary, Hu, Zhiyuan, primary, Li, Yan, primary, Kirk, Erin L., primary, Bethea, Traci N., primary, Perou, Charles M., primary, Palmer, Julie R., primary, Ambrosone, Christine B., primary, Olshan, Andrew F., primary, and Troester, Melissa A., primary

Published
2023
Full Text
View/download PDF

21. Table S6 from Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer

Author

Allott, Emma H., primary, Ebot, Ericka M., primary, Stopsack, Konrad H., primary, Gonzalez-Feliciano, Amparo G., primary, Markt, Sarah C., primary, Wilson, Kathryn M., primary, Ahearn, Thomas U., primary, Gerke, Travis A., primary, Downer, Mary K., primary, Rider, Jennifer R., primary, Freedland, Stephen J., primary, Lotan, Tamara L., primary, Kantoff, Philip W., primary, Platz, Elizabeth A., primary, Loda, Massimo, primary, Stampfer, Meir J., primary, Giovannucci, Edward, primary, Sweeney, Christopher J., primary, Finn, Stephen P., primary, and Mucci, Lorelei A., primary

Published
2023
Full Text
View/download PDF

23. Supplemental Table 1 from Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER Consortium

Author

Chollet-Hinton, Lynn, primary, Olshan, Andrew F., primary, Nichols, Hazel B., primary, Anders, Carey K., primary, Lund, Jennifer L., primary, Allott, Emma H., primary, Bethea, Traci N., primary, Hong, Chi-Chen, primary, Cohen, Stephanie M., primary, Khoury, Thaer, primary, Zirpoli, Gary R., primary, Borges, Virginia F., primary, Rosenberg, Lynn A., primary, Bandera, Elisa V., primary, Ambrosone, Christine B., primary, Palmer, Julie R., primary, and Troester, Melissa A., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Table S2. Agreement between IHC-based and intrinsic subtype, using dichotomous biomarker IHC status from Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

Author

Allott, Emma H., primary, Cohen, Stephanie M., primary, Geradts, Joseph, primary, Sun, Xuezheng, primary, Khoury, Thaer, primary, Bshara, Wiam, primary, Zirpoli, Gary R., primary, Miller, C. Ryan, primary, Hwang, Helena, primary, Thorne, Leigh B., primary, O'Connor, Siobhan, primary, Tse, Chiu-Kit, primary, Bell, Mary B., primary, Hu, Zhiyuan, primary, Li, Yan, primary, Kirk, Erin L., primary, Bethea, Traci N., primary, Perou, Charles M., primary, Palmer, Julie R., primary, Ambrosone, Christine B., primary, Olshan, Andrew F., primary, and Troester, Melissa A., primary

Published
2023
Full Text
View/download PDF

26. Associations between statin use, dose and type and prostate cancer aggressiveness, overall and stratified by race, excluding men who were using non-statin cholesterol-lowering drugs. from Statin Use and Prostate Cancer Aggressiveness: Results from the Population-Based North Carolina–Louisiana Prostate Cancer Project

Author

Allott, Emma H., primary, Farnan, Laura, primary, Steck, Susan E., primary, Arab, Lenore, primary, Su, L. Joseph, primary, Mishel, Merle, primary, Fontham, Elizabeth T.H., primary, Mohler, James L., primary, and Bensen, Jeannette T., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Table S1. Core level agreement between automated and manual scoring of central tissue microarrays from Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

Author

Allott, Emma H., primary, Cohen, Stephanie M., primary, Geradts, Joseph, primary, Sun, Xuezheng, primary, Khoury, Thaer, primary, Bshara, Wiam, primary, Zirpoli, Gary R., primary, Miller, C. Ryan, primary, Hwang, Helena, primary, Thorne, Leigh B., primary, O'Connor, Siobhan, primary, Tse, Chiu-Kit, primary, Bell, Mary B., primary, Hu, Zhiyuan, primary, Li, Yan, primary, Kirk, Erin L., primary, Bethea, Traci N., primary, Perou, Charles M., primary, Palmer, Julie R., primary, Ambrosone, Christine B., primary, Olshan, Andrew F., primary, and Troester, Melissa A., primary

Published
2023
Full Text
View/download PDF

29. Supplementary Table S3. Agreement between three biomarker IHC-based and intrinsic subtypes: impact of adding tumor grade to distinguish between luminal A and luminal B cases. from Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

Author

Allott, Emma H., primary, Cohen, Stephanie M., primary, Geradts, Joseph, primary, Sun, Xuezheng, primary, Khoury, Thaer, primary, Bshara, Wiam, primary, Zirpoli, Gary R., primary, Miller, C. Ryan, primary, Hwang, Helena, primary, Thorne, Leigh B., primary, O'Connor, Siobhan, primary, Tse, Chiu-Kit, primary, Bell, Mary B., primary, Hu, Zhiyuan, primary, Li, Yan, primary, Kirk, Erin L., primary, Bethea, Traci N., primary, Perou, Charles M., primary, Palmer, Julie R., primary, Ambrosone, Christine B., primary, Olshan, Andrew F., primary, and Troester, Melissa A., primary

Published
2023
Full Text
View/download PDF

30. Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study

Author

Troester, Melissa A., Sun, Xuezheng, Allott, Emma H., Geradts, Joseph, Cohen, Stephanie M., Tse, Chiu-Kit, Kirk, Erin L., Thorne, Leigh B., Mathews, Michelle, Li, Yan, Hu, Zhiyuan, Robinson, Whitney R., Hoadley, Katherine A., Olopade, Olufunmilayo I., Reeder-Hayes, Katherine E., Earp, H. Shelton, Olshan, Andrew F., Carey, Lisa A., and Perou, Charles M.

Published
2018
Full Text
View/download PDF

32. Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC

Author

Barr, Martin P., primary, Baird, Anne-Marie, additional, Halliday, Sophia, additional, Martin, Petra, additional, Allott, Emma H., additional, Phelan, James, additional, Korpanty, Greg, additional, Coate, Linda, additional, O’Brien, Cathal, additional, Gray, Steven G., additional, Sui, Jane S. Y., additional, Hayes, Brian, additional, Cuffe, Sinead, additional, and Finn, Stephen P., additional

Published
2022
Full Text
View/download PDF

43. Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21)

Author

Hayes, Brian, primary, Brady, Lauren, additional, Sheill, Gráinne, additional, Baird, Anne-Marie, additional, Guinan, Emer, additional, Stanfill, Bryan, additional, Dunne, Jean, additional, Holden, Dean, additional, Vlajnic, Tatjana, additional, Casey, Orla, additional, Murphy, Verena, additional, Greene, John, additional, Allott, Emma H., additional, Hussey, Juliette, additional, Cahill, Fidelma, additional, Van Hemelrijck, Mieke, additional, Peat, Nicola, additional, Mucci, Lorelei A., additional, Cunningham, Moya, additional, Grogan, Liam, additional, Lynch, Thomas, additional, Manecksha, Rustom P., additional, McCaffrey, John, additional, O’Donnell, Dearbhaile M., additional, Sheils, Orla, additional, O’Leary, John J., additional, Rudman, Sarah, additional, McDermott, Ray, additional, and Finn, Stephen, additional

Published
2021
Full Text
View/download PDF

44. Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications

Author

Allott, Emma, Shan, Yue, Chen, Mengjie, Sun, Xuezheng, Garcia-Recio, Susana, Kirk, Erin L, Olshan, Andrew F, Geradts, Joseph, Earp, H Shelton, Carey, Lisa A, Perou, Charles M, Pfeiffer, Ruth M, Anderson, William F., and Troester, Melissa A.

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Race, Etiology, Epidemiology, Estrogen receptor, Subtype, Breast Neoplasms, Biology, Bimodality, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Age Distribution, SDG 3 - Good Health and Well-being, Internal medicine, medicine, Biomarkers, Tumor, Humans, PAM50, Age of Onset, 030304 developmental biology, Aged, Mixture model, 0303 health sciences, Sequence Analysis, RNA, Gene Expression Profiling, Luminal a, Genomics, Middle Aged, medicine.disease, Immunohistochemistry, 3. Good health, Cancer registry, Gene Expression Regulation, Neoplastic, 030220 oncology & carcinogenesis, Age distribution, Female, Akaike information criterion
Abstract

Purpose Female breast cancer demonstrates bimodal age frequency distribution patterns at diagnosis, interpretable as two main etiologic subtypes or groupings of tumors with shared risk factors. While RNA-based methods including PAM50 have identified well-established clinical subtypes, age distribution patterns at diagnosis as a proxy for etiologic subtype are not established for molecular and genomic tumor classifications. Methods We evaluated smoothed age frequency distributions at diagnosis for Carolina Breast Cancer Study cases within immunohistochemistry-based and RNA-based expression categories. Akaike information criterion (AIC) values compared the fit of single density versus two-component mixture models. Two-component mixture models estimated the proportion of early-onset and late-onset categories by immunohistochemistry-based ER (n = 2860), and by RNA-based ESR1 and PAM50 subtype (n = 1965). PAM50 findings were validated using pooled publicly available data (n = 8103). Results Breast cancers were best characterized by bimodal age distribution at diagnosis with incidence peaks near 45 and 65 years, regardless of molecular characteristics. However, proportional composition of early-onset and late-onset age distributions varied by molecular and genomic characteristics. Higher ER-protein and ESR1-RNA categories showed a greater proportion of late age-at-onset. Similarly, PAM50 subtypes showed a shifting age-at-onset distribution, with most pronounced early-onset and late-onset peaks found in Basal-like and Luminal A, respectively. Conclusions Bimodal age distribution at diagnosis was detected in the Carolina Breast Cancer Study, similar to national cancer registry data. Our data support two fundamental age-defined etiologic breast cancer subtypes that persist across molecular and genomic characteristics. Better criteria to distinguish etiologic subtypes could improve understanding of breast cancer etiology and contribute to prevention efforts.

Published
2019

47. Abstract 2347: Metabolomics profiling of formalin-fixed paraffin-embedded prostate tissues

Author

Halliday, Sophia Rachael, primary, Olsson, Linnea T., additional, Hamilton, Alina, additional, Ramamoorthy, Sivapriya, additional, Kitchen, Jason, additional, Kirk, Erin, additional, Farnan, Laura, additional, Gerstel, Adrian, additional, Troester, Melissa A., additional, Bensen, Jannette T., additional, Wobker, Sara E., additional, and Allott, Emma, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results